Basel Medical Group (BMGL) Competitors $1.91 -0.18 (-8.61%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock BMGL vs. EUDA, SERA, QIPT, BNR, NAKA, ATPC, BDSX, PIII, KDLY, and MRAIShould you be buying Basel Medical Group stock or one of its competitors? The main competitors of Basel Medical Group include EUDA Health (EUDA), Sera Prognostics (SERA), Quipt Home Medical (QIPT), Burning Rock Biotech (BNR), KindlyMD (NAKA), Agape ATP (ATPC), Biodesix (BDSX), P3 Health Partners (PIII), Kindly MD (KDLY), and Marpai (MRAI). These companies are all part of the "healthcare" industry. Basel Medical Group vs. Its Competitors EUDA Health Sera Prognostics Quipt Home Medical Burning Rock Biotech KindlyMD Agape ATP Biodesix P3 Health Partners Kindly MD Marpai Basel Medical Group (NASDAQ:BMGL) and EUDA Health (NASDAQ:EUDA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, valuation, dividends, earnings and analyst recommendations. Do insiders & institutionals have more ownership in BMGL or EUDA? 4.4% of EUDA Health shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has better valuation & earnings, BMGL or EUDA? Basel Medical Group has higher earnings, but lower revenue than EUDA Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBasel Medical GroupN/AN/AN/AN/AN/AEUDA Health$4.01M21.41-$15.36MN/AN/A Do analysts prefer BMGL or EUDA? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Basel Medical Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00EUDA Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00 Is BMGL or EUDA more profitable? Company Net Margins Return on Equity Return on Assets Basel Medical GroupN/A N/A N/A EUDA Health N/A N/A N/A Does the media refer more to BMGL or EUDA? In the previous week, Basel Medical Group and Basel Medical Group both had 2 articles in the media. EUDA Health's average media sentiment score of 0.32 beat Basel Medical Group's score of -0.50 indicating that EUDA Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Basel Medical Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative EUDA Health 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryEUDA Health beats Basel Medical Group on 5 of the 5 factors compared between the two stocks. Get Basel Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for BMGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BMGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BMGL vs. The Competition Export to ExcelMetricBasel Medical GroupMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$38.57M$7.66B$5.73B$9.80BDividend YieldN/A2.76%4.54%4.08%P/E RatioN/A74.7930.7425.12Price / SalesN/A31.41441.05108.85Price / CashN/A23.8337.3459.16Price / BookN/A16.418.886.24Net IncomeN/A$243.33M$3.26B$265.56M7 Day Performance-12.39%1.53%1.73%0.90%1 Month Performance-20.42%2.00%3.54%1.88%1 Year PerformanceN/A16.99%28.63%20.09% Basel Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BMGLBasel Medical GroupN/A$1.91-8.6%N/AN/A$38.57MN/A0.0036News CoverageGap DownEUDAEUDA Health0.8791 of 5 stars$2.61-7.8%N/A-42.7%$96.98M$4.01M0.002Positive NewsGap UpSERASera Prognostics0.8015 of 5 stars$2.47-5.0%N/A-65.7%$93.05M$115K-2.91120QIPTQuipt Home Medical3.2611 of 5 stars$2.13-0.5%$2.85+33.8%-23.4%$92.54M$240.85M-10.141,200News CoverageAnalyst UpgradeBNRBurning Rock Biotech0.368 of 5 stars$6.82+6.2%N/A+60.9%$73.38M$70.67M-3.611,390News CoverageGap UpNAKAKindlyMDN/A$9.57+27.6%N/AN/A$69.91M$2.24M-11.13N/ANews CoverageGap UpATPCAgape ATP0.0804 of 5 stars$1.37+1.5%N/A-36.6%$68.26M$1.29M-2.2740Earnings ReportShort Interest ↑Gap DownBDSXBiodesix3.1408 of 5 stars$0.41-8.3%$1.75+326.8%-75.6%$60.09M$71.32M-1.41220PIIIP3 Health Partners1.7501 of 5 stars$6.53-4.3%$16.25+148.7%-76.8%$46.96M$1.49B-0.14500Earnings ReportShort Interest ↑Analyst RevisionKDLYKindly MDN/A$7.50-1.4%N/A+733.6%$45.17M$2.47M-9.74N/ANews CoveragePositive NewsGap DownMRAIMarpaiN/A$1.34+1.5%N/A+158.2%$22.33M$34.87M-0.51150 Related Companies and Tools Related Companies EUDA Alternatives SERA Alternatives QIPT Alternatives BNR Alternatives NAKA Alternatives ATPC Alternatives BDSX Alternatives PIII Alternatives KDLY Alternatives MRAI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BMGL) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Basel Medical Group Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Basel Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access